Tuesday, February 13, 2018 5:48:48 PM
Exactly...Acceleration, support and advancements of NMUS's pipeline with Emerald steering the ship.
I think we'll see something similar to a IMLF* run in the next several quarters. Lots to look forward to "In Time".
Only way NMUS doesn't look great here, if one doesn't believe in the medicinal benefits of cannabinoid therapies & treatments.
Great share structure. Better than IMLF*.
I got "time" for the potential returns NMUS is capable of.
Don't find this sort of risk reward profile everyday. Maybe once a year if your lucky, imo
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM